What Is The Current and Historic Market Size Analysis Of The Amnion Patch Market?
The amnion patch market has seen considerable growth due to a variety of factors.
• There has been robust growth in the size of the amnion patch market in the last few years. The market, valued at $1.76 billion in 2024, is projected to increase to $1.91 billion in 2025, reflecting a compound annual growth rate of 8.3%.
Fueling this growth during the historic period were factors such as an increased number of chronic wounds and burns, enhancements in healthcare infrastructure, a growing inclination towards natural and biologic products, their escalated usage in managing chronic pain, and the surge in awareness and educational initiatives.
What Are The Predictions for The Amnion Patch Market Size In The Coming Years?
The amnion patch market is expected to maintain its strong growth trajectory in upcoming years.
• The market for the amnion patch is predicted to witness a significant expansion in the coming years, escalating to a worth of $2.6 billion by 2029, reflecting a compound annual growth rate (CAGR) of 8.1%.
Factors contributing to the growth throughout the forecast period include raised awareness and acceptance of bio-products, an escalation in surgical procedures, a heightened emphasis on less invasive treatment options, increasing rates of diabetes, and a rising application of amnion patches in the field of veterinary medicine. Key trends within the forecast period feature advancements in regenerative medicine, ongoing enhancements in the processing and application methods of amnion patches, heightened research and development initiatives, progress in biomaterial science, and the adoption of digital health technologies.
Which Drivers Are Accelerating Growth In The Amnion Patch Market?
The rising incidence of corneal conditions is forecasted to spur the expansion of the amnion patch market. Corneal conditions comprise various disorders impacting the cornea, the clear frontal segment of the eye in charge of directing light onto the retina. Factors such as heightened exposure to environmental stressors and increasing chronic conditions like dry eye disease and diabetes contribute significantly to the surge in corneal conditions. Amnion patches aid in facilitating healing, diminishing inflammation, and preventing scarring in compromised or diseased corneal tissue. For example, a review of Optometry, a scientific double-blind peer-reviewed publication based in the US, reported in April 2024 that fungal keratitis is rare, with a prevalence of 0.03 cases per 100,000 individuals in North America as of 2022. Hence, the rising incidence of corneal conditions is fueling the expansion of the amnion patch market.
What Are The Core Segments Of The Global Amnion Patch Market?
The amnion patch market covered in this report is segmented –
1) By Product Type: Transplantation Grade Amnion Patches, Transplantation Grade Amnion Or Chorion Patches, Suspension Liquid Amnio Patch
2) By Application: Corneal Repair, Ocular Surface Reconstruction, Amniotic Membrane Transplantation, Dental Applications, Wound Healing, Orthopedic Applications
3) By End User: Hospitals, Eye Banks, Clinics, Research Institutes
Subsegments:
1) By Transplantation Grade Amnion Patches: Cryopreserved Transplantation Grade Amnion Patches, Lyophilized Transplantation Grade Amnion Patches, Fresh Transplantation Grade Amnion Patches
2) By Transplantation Grade Amnion or Chorion Patches: Cryopreserved Amnion or Chorion Patches, Lyophilized Amnion or Chorion Patches, Fresh Amnion Or Chorion Patches
3) By Suspension Liquid Amnio Patch: Cryopreserved Suspension Liquid Amnio Patch, Lyophilized Suspension Liquid Amnio Patch, Fresh Suspension Liquid Amnio Patch
Pre-Book The Amnion Patch Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Trends Are Reshaping The Amnion Patch Market Size?
Leading firms in the amnion patch market, such as allografts, are striving to maintain their market dominance by investing in the development of superior products. Allografts are grafts of tissue that have been donated to a recipient of the same species but with different genetics. For instance, in February 2022, Amnio Technology, a company based in the US that specializes in the creation and production of technologies derived from amnions, introduced two new PalinGen membrane products: the Dual-Layer Membrane and the Dual-Layer PalinGen X-Membrane. These fresh allografts, along with all PalinGen membrane products, undergo minimal manipulations, are suitable for homologous application, and they do not contain chorion. They have been specifically designed for patients suffering from acute and chronic wounds that don't heal, as well as patients with complex or open surgical wounds and burns.
Who Are the Key Players In The Amnion Patch Market?
Major companies operating in the amnion patch market are:
• Zimmer Biomet Holdings Inc.
• Enovis
• Integra LifeSciences Corporation
• Globus Medical
• BioHorizons
• HMP Global Inc.
• AlloSource
• Bio-Tissue Inc.
• Infinity Biologics Inc.
• VIVEX Biologics Inc.
• Tissue Regenix Ltd
• Tides Medical
• Ritter Implants
• Celularity
• Spartan Medical Inc.
• Royal Biologics
• ExtremityCare
• NuVision Biotherapies Ltd
• SurgiLogix
• Olifant Biologics
• MTF Biologics
• BioHealing
What Are The Regional Insights Into The Amnion Patch Market?
North America was the largest region in the amnion patch market in 2024. The regions covered in the amnion patch market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
